AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « tocilizumab »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
toc < tocilizumab < tocopherols  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 167.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000002 (2020) L. Horvath [Allemagne] ; B. Hellmich [Allemagne][Treatment of giant cell arteritis and polymyalgia rheumatica].
000003 (2020) Charlotte Girard-Guyonvarc'H ; Michele Iudici[Targeted therapies for connective tissue diseases and vasculitis].
000005 (2020) Tadeusz Płusa[Options for controlling new Corona virus infection - 2019-nCoV].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000007 (2020) Danièle Allali ; Marc Blondon ; Pascale Roux-Lombard ; David Spoerl[How to manage giant cell arteritis].
000011 (2020) Binqing Fu ; Xiaoling Xu ; Haiming WeiWhy tocilizumab could be an effective treatment for severe COVID-19?
000012 (2020) Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis]When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety.
000016 (2020) M. SilbersteinVitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000019 (2020) Martin Michaud [France] ; Florian Catros [France] ; Francis Gaches [France]Usefulness of serum amyloid a protein dosage for monitoring patients receiving tocilizumab.
000020 (2020) Jared Radbel [États-Unis] ; Navaneeth Narayanan [États-Unis] ; Pinki J. Bhatt [États-Unis]Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: A cautionary case report.
000026 (2020) M. Moriyama [Japon] ; Y. Wada [Japon] ; T. Minamoto [Japon] ; M. Kondo [Japon] ; M. Honda [Japon] ; Y. Murakawa [Japon]Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report.
000031 (2020) Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France]Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab.
000036 (2020) B P Hibler [États-Unis] ; A. Markova [États-Unis]Treatment of severe cutaneous adverse reaction with tocilizumab.
000038 (2020) Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne]Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.
000042 (2020) Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000043 (2020) Joana Rodrigues [Oman] ; Daniela Santos-Faria ; Joana Silva ; Soraia Azevedo ; Francisca Guimarães ; Diogo Esperança Almeida ; Filipa Teixeira ; Daniela Peixoto ; Sérgio Alcino ; Carmo Afonso ; José Tavares-CostaTreating Adult-Onset Still Disease With Tocilizumab: A Case-Based Review.
000046 (2020) Gabriela Sanchez-Petitto [États-Unis] ; Noa G. Holtzman [États-Unis] ; Ali Bukhari [États-Unis] ; Matthew Brown [États-Unis] ; Megan K. Morales [États-Unis] ; Madhurima Koka [États-Unis] ; Jean A. Yared [États-Unis] ; Saurabh Dahiya [États-Unis] ; Aaron P. Rapoport [États-Unis] ; Nancy M. Hardy [États-Unis]Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
000048 (2020) Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000049 (2020) Yeimer Ortiz-Martínez [Colombie]Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
000050 (2020) Daichi Fukaya [Japon] ; Tsutomu Inoue [Japon] ; Yuta Kogure [Japon] ; Hiroshi Kajiyama [Japon] ; Keisuke Ishizawa [Japon] ; Takeru Seto [Japon] ; Hajime Hasegawa [Japon] ; Toshihide Mimura [Japon] ; Hirokazu Okada [Japon]Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.
000051 (2020) Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "tocilizumab" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "tocilizumab" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    tocilizumab
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021